All systems go for AFT Pharmaceuticals

All systems go for AFT Pharmaceuticals
Hartley Atkinson: negative economy won't impact growth. (Image: Supplied)
Brent Melville
AFT Pharmaceuticals expects to make inroads into the Australian market on the strength of its new Maxigesic sinus and pain treatment and hot drink sachet products.Product sales in Australia have steadily improved after the listed pharmaceutical group's successful legal appeal against British-based consumer products giant Reckitt Benckiser, allowing AFT to compare its products with paracetamol and ibuprofen in its advertising.That helped push overall product sales and royalties up by 30% during the half year to September 2022, though first-h...

More Markets

ANZ bank staff worried about restructure 'conversations'
Economy

ANZ bank staff worried about restructure 'conversations'

As ANZ confronts 'Nuno-geddon', ANZ NZ says it's business as usual over here.

Small Cap Wrap: It's all about AGMs
Markets

Small Cap Wrap: It's all about AGMs

Burger Fuel's covid hangover and court costs, Third Age, Solution Dynamics, and more.

‘Pretty big beat’: Hallenstein Glasson impresses
Retail

‘Pretty big beat’: Hallenstein Glasson impresses

Hallenstein Glasson’s profit range beat Forsyth Barr forecasts by 15%.

Me Today sets its sights on UAE
Markets

Me Today sets its sights on UAE

Outside of China and NZ, other priority markets are Japan, the US and Ireland.